Clinical Trials Directory

Trials / Completed

CompletedNCT06078072

Biomaterials and Mesenchymal Stem/Stromal Cells in the Treatment of Knee Articular Surface Lesions

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
University Medical Centre Ljubljana · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers

Summary

The goal of this observational study is to evaluate the combined single-step approach with biomaterials and mesenchymal stem/stromal cells in the treatment of knee articular surface lesions. The clinical analysis of the treatment outcomes, regarding postoperative improvements and safety, is going to be accompanied with laboratory analysis of the intraoperatively applied cellular products. The main hypothesis are: (1) such combined single-step procedure significantly improves patients' functioning and quality of life; (2) this therapeutic approach is safe; (3) cellular parameters of the applied filtered bone marrow aspirate (fBMA) impact treatment outcomes, among other potential predictors. Researchers will compare subjective (questionnaire) and objective (clinical examination) status of patients before and after the operation, record any potential complications and perform regression analysis to assess the influence of potential predictors on postoperative improvements.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiomaterials augmented with mesenchymal stem/stromal cellsCombined single-step procedure of treating knee articular surface lesions with biomaterials (scaffolds) and mesenchymal stem cells (filtered bone marrow aspirate concentrate)

Timeline

Start date
2022-09-01
Primary completion
2023-08-31
Completion
2023-10-31
First posted
2023-10-11
Last updated
2023-11-30

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT06078072. Inclusion in this directory is not an endorsement.